John and his team raised $12 million in a private placement of common stock for Viveve Medical, Inc. (Nasdaq: VIVE). Stonepine Capital, L.P. was the lead subscriber in the offering. Viveve is a women’s health company committed to advancing new solutions to improve women’s overall well-being and quality of life. Viveve plans to use the net proceeds from the offering to support the commercial launch of the ViveveSystem in the 12 countries where it is available through select distributors.

Note: This work was performed prior to joining Stout.